Highlighting the validation of low-dose CT scans for screening high-risk patients, the nonprofit organization Lung Cancer Alliance (LCA) is reporting significant improvement for early lung cancer detection in its annual National Report Card on Lung Cancer.
In a statement, Laurie Fenton Ambrose, LCA's president and CEO, said that the scientific validation of the use of low-dose CT scans for screening high-risk patients was by far the most significant development in lung cancer research in the past year. She described this development as a "game changer" and a life-saving breakthrough that the LCA will work to see brought into the U.S. public health system safely, equitably, and efficiently.
In addition to lauding the progress in early detection, the LCA also acknowledged improvements in the U.S. government's response to a call to action on lung cancer policy, as well as growing support among lung cancer awareness advocates for making lung cancer a public health priority.
